Show simple item record

dc.contributor.authorKarplus, Martin
dc.contributor.authorOvchinnikov, Victor A
dc.contributor.authorLouveau, Joy E
dc.contributor.authorBarton, John P
dc.contributor.authorChakraborty, Arup K
dc.date.accessioned2018-05-01T19:16:53Z
dc.date.available2018-05-01T19:16:53Z
dc.date.issued2018-02
dc.date.submitted2017-10
dc.identifier.issn2050-084X
dc.identifier.urihttp://hdl.handle.net/1721.1/115144
dc.description.abstractEliciting antibodies that are cross reactive with surface proteins of diverse strains of highly mutable pathogens (e.g., HIV, influenza) could be key for developing effective universal vaccines. Mutations in the framework regions of such broadly neutralizing antibodies (bnAbs) have been reported to play a role in determining their properties. We used molecular dynamics simulations and models of affinity maturation to study specific bnAbs against HIV. Our results suggest that there are different classes of evolutionary lineages for the bnAbs. If germline B cells that initiate affinity maturation have high affinity for the conserved residues of the targeted epitope, framework mutations increase antibody rigidity as affinity maturation progresses to evolve bnAbs. If the germline B cells exhibit weak/moderate affinity for conserved residues, an initial increase in flexibility via framework mutations may be required for the evolution of bnAbs. Subsequent mutations that increase rigidity result in highly potent bnAbs. Implications of our results for immunogen design are discussed.en_US
dc.publishereLife Sciences Publications, Ltden_US
dc.relation.isversionofhttp://dx.doi.org/10.7554/eLife.33038en_US
dc.rightsCreative Commons Attribution 4.0 International Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.sourceeLifeen_US
dc.titleRole of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodiesen_US
dc.typeArticleen_US
dc.identifier.citationOvchinnikov, Victor et al. “Role of Framework Mutations and Antibody Flexibility in the Evolution of Broadly Neutralizing Antibodies.” eLife 7 (February 2018): e33038 © Ovchinnikov et alen_US
dc.contributor.departmentInstitute for Medical Engineering and Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistryen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Physicsen_US
dc.contributor.mitauthorOvchinnikov, Victor A
dc.contributor.mitauthorLouveau, Joy E
dc.contributor.mitauthorBarton, John P
dc.contributor.mitauthorChakraborty, Arup K
dc.relation.journaleLifeen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-04-24T18:34:46Z
dspace.orderedauthorsOvchinnikov, Victor; Louveau, Joy E; Barton, John P; Karplus, Martin; Chakraborty, Arup Ken_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-9506-5840
dc.identifier.orcidhttps://orcid.org/0000-0003-1467-421X
dc.identifier.orcidhttps://orcid.org/0000-0003-1268-9602
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record